The pharmaceutical company Bayer Pharmaceuticals started producing Levitra in 2007. This drug was technologically developed exclusively for the men’s erectile dysfunction treatment, and therefore its base consists of the most up-to-date and pioneering introductions in the field of pharmaceutics.
The main active ingredient of Levitra is Vardenafil Australia. This drug has a wide range of the advantages before other drugs for the treatment of the erectile dysfunction. One of the most essential advantages is a speed of the onset of the pharmacological action. Vardenafil is instantly taken from the gastrointestinal tract and gets into the blood, and that is why the action starts in 10 minutes after the use of the tablet. Levitra relaxes the smooth muscles of the penis and dilates the vessels of the arteries due to which the blood flow is increased in the penis, and thus the man experiences the improvement of the erection. At the same time, the main active component Vardenafil narrows veins reducing the outflow of the blood and maintaining erection until the end of the sexual intercourse.
One more advantage of Levitra is a rather high pharmacological safety. This drug provides less stress on the cardiovascular system than other medications, and therefore it is indicated for the use by the aged men older than 60 years old.
Levitra is released in the tablets of the orange colour for the perioral usage. The tablets must not be broken and chewed. They are swallowed entirely and taken with plenty of the liquid for the better dissolution. Fatty food does not affect the uptake of the active components.
The minimal dose of Levitra, which is recommended is 10 mg per day. Take the tablet 10-15 minutes before the sexual intimacy, after which the tablet starts its pharmacological action under the sexual stimulation.
If the required pharmacological effect is not provided by the minimal Levitra of 10 mg, it is possible to increase it twice as many but only if there are no contraindications for it. The action of 1 tablet lasts 6-8 hours.